Patent intelligence · Companies
Company patent strength
Non-educational filers ranked by their patent portfolio. Grant rate and lapsed share expose where high filing volume is not matched by granted patents. Domestic filers lead — toggle to foreign applicants to see who is entering the Indian market.
Free to browse the ranking. Sign into open a filer's full profile — inventors, filing trend and quality index. See how we rank.
Why this page exists — and how to read it
Filing volume and IP quality are different things. This leaderboard ranks non-educational filers by portfolio, but the grant-rate and lapsed sorts are where the judgement lives: they separate companies whose filings survive examination from those accumulating paper.
- Investors
- High grant rate on steady filing usually means a real R&D engine; big volume with a high lapsed share is a red flag worth asking about.
- Founders & operators
- These are the incumbents and potential acquirers in your space — open a filer to see the walls you'd build against.
- Corporate & R&D
- Benchmark competitors' portfolios and grant rates; toggle to foreign to watch who is entering the Indian market.
💬 The grant-rate sort applies a 20-filing floor so tiny portfolios can't top the list.
3,207 foreign filers with 5+ patents · page 64
| # | Filer | Patents↓ | Granted↓ | Lapsed↓ | Pending↓ | Active |
|---|---|---|---|---|---|---|
| 3151 | TREETOTEXTILE | 5 | 00% | 0 | 5 | 2023–2025 |
| 3152 | TRINSEO EUROPE | 5 | 00% | 0 | 5 | 2026–2026 |
| 3153 | TRUKING TECHNOLOGY | 5 | 240% | 0 | 3 | 2022–2026 |
| 3154 | TSCAN THERAPEUTICS | 5 | 00% | 0 | 5 | 2023–2024 |
| 3155 | TTP | 5 | 00% | 0 | 5 | 2022–2026 |
| 3156 | TULA TECHNOLOGY | 5 | 00% | 3 | 2 | 2022–2025 |
| 3157 | TURNING POINT THERAPEUTICS | 5 | 00% | 3 | 2 | 2022–2022 |
| 3158 | ULTIMATE EOR SERVICES | 5 | 00% | 0 | 5 | 2024–2026 |
| 3159 | UNION THERAPEUTICS A S | 5 | 00% | 2 | 3 | 2022–2023 |
| 3160 | UNISOC CHONGQING TECHNOLOGIES | 5 | 120% | 0 | 4 | 2022–2022 |
| 3161 | UNITIKA | 5 | 00% | 0 | 5 | 2022–2026 |
| 3162 | USG INTERIORS | 5 | 00% | 0 | 5 | 2022–2025 |
| 3163 | VALEO SYST MES D ESSUYAGE | 5 | 00% | 0 | 5 | 2022–2026 |
| 3164 | VANOCUR REFRACTORIES | 5 | 00% | 0 | 5 | 2024–2024 |
| 3165 | VDM METALS INTERNATIONAL | 5 | 00% | 0 | 5 | 2022–2024 |
| 3166 | VELICO MEDICAL | 5 | 00% | 0 | 5 | 2025–2025 |
| 3167 | VERDESIAN LIFE SCIENCES U S | 5 | 00% | 0 | 5 | 2023–2026 |
| 3168 | VERMEER MANUFACTURING | 5 | 00% | 0 | 5 | 2022–2024 |
| 3169 | VERONA PHARMA | 5 | 120% | 0 | 4 | 2022–2026 |
| 3170 | VERSAMEB | 5 | 00% | 5 | 0 | 2022–2024 |
| 3171 | VIFOR INTERNATIONAL | 5 | 00% | 0 | 5 | 2022–2024 |
| 3172 | VIIV HEALTHCARE UK NO 5 | 5 | 00% | 1 | 4 | 2022–2026 |
| 3173 | VISCOFAN | 5 | 00% | 0 | 5 | 2023–2024 |
| 3174 | VISTAGEN THERAPEUTICS | 5 | 00% | 2 | 3 | 2022–2026 |
| 3175 | VOESTALPINE STAHL | 5 | 00% | 0 | 5 | 2024–2026 |
| 3176 | VOESTALPINE TURNOUT TECHNOLOGY ZELTWEG | 5 | 00% | 0 | 5 | 2025–2025 |
| 3177 | VOLASTRA THERAPEUTICS | 5 | 00% | 0 | 5 | 2022–2025 |
| 3178 | VOLKSWAGEN AKTIENGESELLSCHAFT | 5 | 00% | 0 | 5 | 2022–2025 |
| 3179 | VORTEX PIPE SYSTEMS | 5 | 120% | 0 | 4 | 2022–2024 |
| 3180 | VOSS AUTOMOTIVE | 5 | 00% | 0 | 5 | 2024–2025 |
| 3181 | W HNER BESITZ | 5 | 00% | 0 | 5 | 2026–2026 |
| 3182 | WAHL CLIPPER | 5 | 00% | 0 | 5 | 2022–2026 |
| 3183 | WALTER STAUFFENBERG KG | 5 | 00% | 0 | 5 | 2022–2025 |
| 3184 | WATSON MARLOW | 5 | 480% | 0 | 1 | 2022–2024 |
| 3185 | WATTRII | 5 | 00% | 0 | 5 | 2023–2025 |
| 3186 | WIELAND PROVIDES SRL | 5 | 00% | 0 | 5 | 2024–2026 |
| 3187 | WIND SOLUTIONS A S | 5 | 00% | 0 | 5 | 2024–2025 |
| 3188 | WORLDLINE | 5 | 00% | 0 | 5 | 2022–2026 |
| 3189 | XEBEC TECHNOLOGY | 5 | 00% | 0 | 5 | 2022–2024 |
| 3190 | XEROS | 5 | 00% | 2 | 3 | 2022–2023 |
| 3191 | XIAOGAN CORNEX NEW ENERGY INNOVATION TECHNOLOGY | 5 | 00% | 0 | 5 | 2024–2024 |
| 3192 | XILIS | 5 | 00% | 0 | 5 | 2025–2025 |
| 3193 | Y BIOLOGICS | 5 | 00% | 0 | 5 | 2022–2024 |
| 3194 | Y MABS THERAPEUTICS | 5 | 00% | 0 | 5 | 2022–2025 |
| 3195 | YIELD ENGINEERING SYSTEMS | 5 | 00% | 0 | 5 | 2026–2026 |
| 3196 | YODLEE | 5 | 120% | 3 | 1 | 2022–2024 |
| 3197 | YONEX | 5 | 120% | 0 | 4 | 2022–2026 |
| 3198 | YUSUR TECHNOLOGY | 5 | 00% | 0 | 5 | 2024–2024 |
| 3199 | ZAHORANSKY | 5 | 00% | 2 | 3 | 2022–2026 |
| 3200 | ZEALAND PHARMA A S | 5 | 120% | 0 | 4 | 2019–2025 |
Educational institutes are excluded — see the institute leaderboard. Attribution is by patent assignee record; a jointly-owned patent is credited to each co-owner, so a co-filed patent counts for every company on it. "Lapsed" = abandoned, withdrawn, deemed-withdrawn or refused; "Pending" = awaiting examination or in prosecution. Want to filter by technology or value category? Browse the filer explorer →
Rankings use patent-registry status (grant rate, examination, claim depth) as a quality proxy — directional, not advice; see methodology. Read the ranking methodology →